MAIA Biotechnology, Inc., (NYSE American ... of common stock at a purchase price of $1.50 per share, in a private placement to accredited investors and a Company director. Each share of common ...

MAIA Biotechnology, Inc. (NYSE:MAIA), a clinical-stage biopharmaceutical company, has announced a private placement agreement to raise approximately $695,000. The company will issue 463,332 shares ...

CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology, Inc., (NYSE American ... stock at a purchase price of $1.50 per share, in a private placement to accredited investors and a Company director.

MAIA Biotechnology, Inc., (NYSE American ... of common stock at a purchase price of $1.50 per share, in a private placement to accredited investors and a Company director. Each share of common ...

All other aspects of the announcement remain the same. The updated release reads: MAIA BIOTECHNOLOGY ANNOUNCES PRIVATE PLACEMENT OF APPROXIMATELY $695,000 MAIA Biotechnology, Inc. (MAIA), (“MAIA ...

MAIA Biotechnology, Inc. (NYSE:MAIA), a clinical-stage biopharmaceutical company, has announced a private placement agreement to raise approximately $695,000. The company will issue 463,332 shares of ...

The number of shares and expected proceeds from the private placement have been corrected ... of the announcement remain the same. MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA ...

Additionally, MAIA Biotechnology secured $1.08 million through a private placement deal, selling approximately 720,000 shares to accredited investors and company directors. The funds are designated to ...